ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,731,666, issued on Sept. 8, was assigned to Caris MPI Inc. (Irving, Texas).
"Pan-cancer platinum response predictor" was invented by Jim Abraham (Southlake, Texas), Wolfgang Michael Korn (Mill Valley, Calif.) and David Spetzler (Paradise Valley, Ariz.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Comprehensive molecular profiling provides a wealth of data concerning the molecular status of patient samples. Such data can be compared to patient response to treatments to identify biomarker signatures that predict response or non-response to such treatments. This approach has been applied to identify biomarker signatures that correlate with response of can...